ERBB2 and glioblastoma: Since then, many more targets have been used in the design of CAR T cells, including human epidermal growth factor 2 (HER2), erythropoietin-producing hepatocellular carcinoma A2 (EphA2), and epidermal growth factor receptor variant III (EGFRvIII), which is expressed in a subset of GBM and not in healthy brains [134,135,136].